RRID:SCR_018271 | Madison, WI 53713 | 2D-PAGE, Proteomics, SDS-PAGE, Antibody Characterization, Antibody Production, Polyclonal Antibody Production, Proteomics Analysis | 03/06/2024 |
RRID:SCR_021772 | New York, NY 11967 | Assay Development, Monoclonal Antibody, Drug Discovery, Protease Inhibitor Assay Of SARS-CoV-2, SARS-CoV-2 Virus-like Particles (VLPs), Cell Lines For SARS-CoV-2 Research, SARS-CoV-2 Aptamers, SARS-CoV-2 CPE Assay, SARS-CoV-2 Spike-pseudovirus Based Neutralization Assay Services | 10/19/2023 |
RRID:SCR_021767 | New York, NY 11967 | Antibody Sequencing, Monoclonal Antibody, Sequencing - Next Generation Sequencing (NGS), Sequencing - Protein Sequencing, Sequencing - Pyrosequencing, Immunoassay, Single-Cell Analysis, Single-cell Sequencing, Whole Genome Amplification (WGA), Drug Discovery, Assay Development | 08/15/2023 |
RRID:SCR_021779 | New York, NY 10065 | FACS Cell Sorting, Flow Cytometric Analysis, Flow Cytometry Data Analysis, Imaging Flow Cytomtry, Confocal Microscopy | 10/21/2021 |
RRID:SCR_018952 | Beaverton, OR 97008 | Computational - Application Development, Data Analysis, Data Processing And Interpretation | 08/21/2020 |
Private Company
17 Ramsey Road, Shirley, NY 11967, USA
New York, NY 11967
United States of Americahttps://sars-cov-2.creative-biolabs.com/cite this facility
Bella Smith
Last Updated: 10/19/2023
Creative Biolabs has conducted extensive and in-depth research on the MERS epidemic in 2012, and has contributed a lot to the research and control of coronavirus pneumonia, and thus has accumulated a lot of experience. Therefore, at the end of 2019, when a new type of coronavirus pneumonia (which is officially named by the WHO as coronavirus disease 2019, abbreviated "COVID-19" on Feb 11, 2020) broke out in Wuhan, China, Creative Biolabs quickly organized relevant researchers, and set up a dedicated research team to carry out intensive analysis and research on the SARS-COV2 virus (formerly known as 2019-nCoV). The team has rapidly developed related proteins, antibodies, nucleic acid extraction kits and other products to help researchers quickly develop effective anti-COVID-19 drugs and vaccines. Relying on our mature drug development and vaccine development technology and experience, we also provide researchers with excellent CRO services regarding to discovery services of anti-SARS-COV2 (COVID-19, 2019-nCoV) drugs as well as vaccine development services, preclinical research services, various in vivo and in vivo research models, and in vivo diagnostic immunoassay services.
Comprehensive COVID-19/ SARS-COV2/ 2019-nCoV Research Tools and Services
Services are offerred outside of Private Company
Consulting is offerred outside of Private Company